Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains
Stopped The study was terminated due to difficulty identifying eligible participants and the expiration of funding.
Conditions
Interventions
- DRUG: Losartan
- DRUG: Placebo
Sponsor
James J. Irrgang
Collaborators
- [object Object]
- [object Object]